Cargando…
Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy
Intratumoural heterogeneity underlies tumour escape from molecularly targeted therapy in glioblastoma. A cell-based model preserving the evolving molecular profiles of a tumour during treatment is key to understanding the recurrence mechanisms and development of strategies to overcome resistance. In...
Autores principales: | Tanaka, Shota, Luk, Samantha, Kiyokawa, Juri, Onozato, Maristela L., Iafrate, A. John, Shah, Khalid, Martuza, Robert L., Rabkin, Samuel D., Batchelor, Tracy T., Cahill, Daniel P., Chi, Andrew S., Wakimoto, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333836/ https://www.ncbi.nlm.nih.gov/pubmed/30644426 http://dx.doi.org/10.1038/s41598-018-37437-2 |
Ejemplares similares
-
Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
por: Li, Ming, et al.
Publicado: (2020) -
Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma
por: Kawamura, Yoichiro, et al.
Publicado: (2022) -
Immunovirotherapy for glioblastoma
por: Ning, Jianfang, et al.
Publicado: (2014) -
Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma
por: Ning, Jian-Fang, et al.
Publicado: (2019) -
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
por: Kiyokawa, Juri, et al.
Publicado: (2019)